{"SPADE_UN_26873": {"Sequence Information": {"Peptide Name": "Smp24 [W2A]", "Sequence": "IASFLIKAATKLLPSLFGGGKKDS", "Sequence Length": 24, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Improving the Therapeutic Index of Smp24, a Venom-Derived Antimicrobial Peptide: Increased Activity against Gram-Negative Bacteria", "Pubmed ID": "35887325", "Reference": "Int J Mol Sci. 2022;23:7979", "Author": "Rawson KM, Lacey MM, Strong PN, Miller K", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/35887325"}], "Mass": 2462.92, "PI": 10.0, "Net Charge": 3, "Hydrophobicity": 0.42, "Frequent Amino Acids": "KLA", "Absent Amino Acids": "CEHMNOQRUVWY", "Basic Residues": 4, "Acidic Residues": 1, "Hydrophobic Residues": 11, "Polar Residues": 13, "Positive Residues": 4, "Negative Residues": 1, "SPADE ID": "SPADE_UN_26873", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_26873", "Similarity": 1.0, "Sequence": "IASFLIKAATKLLPSLFGGGKKDS"}, {"SPADE_ID": "SPADE_N_05678", "Similarity": 0.9583333333333334, "Sequence": "IWSFLIKAATKLLPSLFGGGKKDS"}, {"SPADE_ID": "SPADE_N_11377", "Similarity": 0.9473684210526315, "Sequence": "IWSFLIKAATKLLPSLFGG"}], "Hemolytic Activity": "Sheep erythrocytes:50% Hemolysis=>512 µg/ml,Human embryonic kidney HEK293 cells:LD50=72 µg/ml", "Target Organism": "Escherichia coli JM109(MIC=64µg/ml),Escherichia coli JM109(MIC=64µg/ml),Pseudomonas aeruginosa H085180216(MIC=128µg/ml),Pseudomonas aeruginosa H085180216(MBC=256µg/ml),Staphylococcus aureus SH1000(MIC=32µg/ml),Staphylococcus aureus SH1000(MBC=64µg/ml),Human hepatocellular carcinoma HepG2(LD50=121µg/ml)"}}}